A positive effect of p21(cip1/waf1) in the colony formation from murine myeloid progenitor cells as assessed by retroviral-mediated gene transfer

Blood Cells, Molecules and Diseases

Volumn 24, Issue 2, 1998, Pages 138-148

  Braun, Stephen E ^a,b   Mantel, Charlie ^a,b   Rosenthal, Marc ^a   Cooper, Scott ^a,b   Liu, Lisa ^a,b   Robertson, Kent A ^a   Hromas, Robert ^a,b   Broxmeyer, Hal E ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WALTHER CANCER INSTITUTE   (United States)

Author keywords

Gene transfer; Hematopoietic progenitor cells; p21(cip1 waf1); p21(cip1 waf1) knockout mice

Indexed keywords

PROTEIN P21; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; HYBRID PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; RETROVIRUS; ANIMAL; C3H MOUSE; CELL CULTURE; CELL CYCLE; CLONOGENIC ASSAY; CULTURE MEDIUM; CYTOLOGY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; LYMPHOCYTE; MOLONEY LEUKEMIA ONCOVIRUS; PHYSIOLOGY; PROMOTER REGION; SECRETION; SPLEEN;

ANIMALS; CELL CYCLE; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENETIC VECTORS; LYMPHOCYTES; MICE; MICE, INBRED C3H; MOLONEY MURINE LEUKEMIA VIRUS; PROMOTER REGIONS (GENETICS); RECOMBINANT FUSION PROTEINS; SPLEEN; TRANSFECTION;

EID: 0032081244     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0181     Document Type: Article

References (38)

1. 1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995.
2. 2. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993.
3. 3. Harper JW, Elledge SJ, Keyomarsi K, et al. Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6: 387-400, 1995.
4. 4. LaBaer J, Garrett MD, Stevenson LF, et al. New functional activities for p21 family of CDK inhibitors. Genes Dev 11:847-862, 1997.
5. 5. El-Deiry W, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
6. WAF1/CIP1. Nature 389:187-190, 1997.
7. 7. Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA. Mechanisms of regulation of WAF1/CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 9:3407-3415, 1994.
8. 8. Macleod KF, Sherry N, Hannon G, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9:935-944, 1995.
9. WAF1/CIP1 expression by p53-independent pathways. Oncogenes 12:1557-1564, 1996.
10. WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway. Cancer Res 56:31-35, 1996.
11. 11. Nourse J, Firpo E, Flanagan WM, et al. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372: 570-573, 1994.
12. 12. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME. Induction of p21 (WAF-1/ CIP1) during differentiation. Oncogene 9: 3389-3396, 1994.
13. cip-1 in the maintenance of stem/progenitor cells in vivo. Blood 88:3710-3719, 1996.
14. 14. Jiang H, Lin J, Su Z, Collart FR, Huberman E, Fisher PB. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397-3406, 1994.
15. 15. Halevy O, Novitch BG, Spicer DB, et al. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1021.
16. 16. Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Gene Dev 8:1750-1758, 1994.
17. 17. Shiohara M, El-Deiry WS, Wada M, et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 84(11):3781-4, 1994.
18. 18. Watanabe H, Fukuchi K, Takagi Y, Tomoyasu S, Tsuruoka N, Gomi K. Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors. Biochim Biophys Acta, 1263:3, 275-80, 1995.
19. cip1/waf1 undergo normal development, but are defective in G1 checkpoint control. Cell 82:675-684, 1995.
20. 20. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-21, 1992.
21. 21. Fero ML, Rivkin M, Tasch M, et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-44, 1996.
22. 22. Miller AD, Rosman GJ. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980, 1989.
23. 23. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6:2895, 1986.
24. 24. Spangrude GJ, Smith L, Uchida N, et al. Mouse hematopoietic stem cells. Blood 78:1395-1402, 1991.
25. 25. Traycoff CM, Cornetta K, Yoder MC, Davidson A, Srour EF. Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. Exp Hematol 24:299-306, 1996.
26. 26. Cooper S, Broxmeyer HE. Clonogenic methods in vitro for the enumeration of granulocyte-macrophage progenitor cells (CFU-GM) in human bone marrow and mouse bone marrow and spleen. J Tiss Cult Meth 13:77-82, 1991.
27. 27. Cooper S, Broxmeyer HE. Measurement of interleukin-3 and other hematopoietic growth factors, such as GM-CSF, G-CSF, M-CSF, erythropoietin and the potent co-stimulating cytokines steel factor and Flt-3 ligand. In: Coligan, J.E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M., Strober, W., Coico, R. (eds). Current Protocols in Immunology. New York: John Wiley & Sons, Inc., Suppl 18, pp. 6.4.1-6.4.12, 1996.
28. 28. Bender MA, Gelinas RE, Miller AD. A majority of mice show long-term expression of a human betaglobin gene after retrovirus transfer into hematopoietic stem cells. Mol Cell Biol 9:1426-34, 1989.
29. 29. Miyazawa K, Hendrie PC, Mantel C, Wood K, Ashman LK, Broxmeyer HE. Comparative analysis of signaling pathways between mast cell growth factor (c-kit ligand) and granulocyte-macrophage colony stimulating factor in a human factor-dependent myeloid cell line involves phosphorylation of Raf-1, GTPase-activating protein and mitogen-activated protein kinase. Exp Hematol 19:1110-1123, 1991.
30. 30. Brizzi MF, Aini MG, Aronica MG, Blechman JM, Yarden Y, Pegoraro L. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinases. J Biol Chem 269:31680-31684, 1994.
31. 31. Mui AL, Wakao H, Harada N, O'Farell A, Miyajima A. Interleukin-3, granulocyte-macrophage colony stimulating factor, and interleukin-5 transduce signals through two forms of STAT5. J Leukoc Biol 57:799-803, 1995.
32. 32. Gotoh A, Takahira H, Mantel C, Broxmeyer HE. Hyper-phosphorylation of STAT3 by steel factor in human growth factor-dependent myeloid cell lines. Blood 86 (Suppl 1):152a, 1995.
33. 33. Horie M, Broxmeyer HE. Involvement of immediate-early gene expression in the synergistic effects of steel factor in combination with granulocyte-macrophage colony stimulating factor or interleukin-3 on proliferation of a human factor-dependent cell line. J Biol Chem 268:968-973, 1993.
34. 34. Horie M, Broxmeyer HE. The combination of Steel factor and GM-CSF blocks apoptosis induced by retinoic acid and upregulates AP-1 in a in a human growth factor-dependent cell line. Exp Hematol 23:168-173, 1995.
35. 35. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ, Kato JY. D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14:2066-2076, 1994.
36. 36. Broxmeyer, H.E. 1997. The hematopoietic system: principles of therapy with hematopoietically active cytokines. In: (Ganser, A., Hoelzer, D., eds.) Cytokines in the Treatment of Hematopoietic Failure. New York: Marcel Dekker, in press.
37. 37. Wang J, Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359-361, 1960.
38. 38. de Nooij, JC, Harikharn, IK. Uncoupling cell fate determination from patterned cell division in the Drosophilia eye. Science 270:983-985, 1995.